Contingent negative variation in patients with deficit schizophrenia or bipolar I disorder with psychotic features: Measurement and correlation with clinical characteristics

Nordic Journal of Psychiatry

Volumn 69, Issue 3, 2015, Pages 196-203

  Li, Zhe ^a   Deng, Wei ^a   Liu, Xiang ^a   Zheng, Zhong ^a   Li, Mingli ^a   Li, Yinfei ^a   Han, Yuanyuan ^a   Ma, Xiaohong ^a   Wang, Qiang ^a   Liu, Xiehe ^a   Li, Tao ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Bipolar disorder; Contingent negative variation; Deficit schizophrenia; Event related potentials

Indexed keywords

ADULT; ARTICLE; AUDITORY STIMULATION; BIPOLAR I DISORDER; CLINICAL FEATURE; CONTINGENT NEGATIVE VARIATION; CONTROLLED STUDY; DISEASE DURATION; DISEASE MARKER; ELECTROOCULOGRAM; EVOKED RESPONSE; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; ONSET AGE; PHENOTYPE; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOSIS; REACTION TIME; SCHIZOPHRENIA; SEX DIFFERENCE; SMOKING HABIT; YOUNG MANIA RATING SCALE; ADOLESCENT; BIPOLAR DISORDER; BRAIN; CASE CONTROL STUDY; ELECTROENCEPHALOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BIPOLAR DISORDER; BRAIN; CASE-CONTROL STUDIES; CONTINGENT NEGATIVE VARIATION; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; REACTION TIME; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84924862853     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.3109/08039488.2014.959562     Document Type: Article

References (58)

1. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 2005;10:40-68;image 5.
2. Owen MJ, Williams NM, O'Donovan MC. The molecular genetics of schizophrenia: New findings promise new insights. Mol Psychiatry 2004;9:14-27.
3. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 2003;73:34-48.
4. Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI, Jr., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet 2003;73:49-62.
5. Wonodi I, Mitchell BD, Stine OC, Hong LE, Elliott A, Kirkpatrick B, et al. Lack of association between COMT gene and deficit/nondeficit schizophrenia. Behav Brain Funct 2006;2:42.
6. Buckley PF, Pillai A, Evans D, Stirewalt E, Mahadik S. Brain derived neurotropic factor in first-episode psychosis. Schizophr Res 2007;91:1-5.
7. Abbott A. Psychiatric genetics: The brains of the family. Nature 2008;454:154-7.
8. Gottesman, II, Gould TD. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry 2003;160:636-45.
9. Maj M. Critique of the DSM-IV operational diagnostic criteria for schizophrenia. Br J Psychiatry 1998;172:458-60.
10. Tsuang MT, Stone WS, Faraone SV. Toward reformulating the diagnosis of schizophrenia. Am J Psychiatry 2000;157:1041-50.
11. Carpenter WT, Jr., Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: The concept. Am J Psychiatry 1988;145:578-83.
12. Mucci A, Galderisi S, Kirkpatrick B, Bucci P, Volpe U, Merlotti E, et al. Double dissociation of N1 and P3 abnormalities in deficit and nondeficit schizophrenia. Schizophr Res 2007;92:252-61.
13. Santos JL, Sanchez-Morla EM, Aparicio A, Garcia-Jimenez MA, Villanueva C, Martinez-Vizcaino V, et al. P50 gating in deficit and nondeficit schizophrenia. Schizophr Res 2010;119:183-90.
14. Almasy L, Blangero J. Endophenotypes as quantitative risk factors for psychiatric disease: Rationale and study design. Am J Med Genet 2001;105:42-4.
15. Gould TD, Gottesman, II. Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav 2006;5:113-9.
16. Braff DL, Freedman R, Schork NJ, Gottesman, II. Deconstructing schizophrenia: An overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull 2007;33:21-32.
17. Pfefferbaum A, Roth WT, Ford JM. Event-related potentials in the study of psychiatric disorders. Arch Gen Psychiatry 1995;52:559-63.
18. Hall MH, Rijsdijk F, Picchioni M, Schulze K, Ettinger U, Toulopoulou T, et al. Substantial shared genetic influences on schizophrenia and event-related potentials. Am J Psychiatry 2007;164:804-12.
19. Wegrzyn J. P50 sensory gating disorders of auditory evoked potentials (AEP) in persons with schizophrenia. Psychiatr Pol 2004;38:833-45.
20. Wegrzyn J, Wciorka J. P50 component of auditory evoked potentials in persons with schizophrenia and their first degree relatives. Psychiatr Pol 2004;38:395-408.
21. Arnfred SM. Exploration of auditory P50 gating in schizophrenia by way of difference waves. Behav Brain Funct 2006;2:6.
22. Hall MH, Schulze K, Sham P, Kalidindi S, McDonald C, Bramon E, et al. Further evidence for shared genetic effects between psychotic bipolar disorder and P50 suppression: A combined twin and family study. Am J Med Genet B Neuropsychiatr Genet 2008;147B:619-27.
23. Frommann I, Brinkmeyer J, Ruhrmann S, Hack E, Brockhaus-Dumke A, Bechdolf A, et al. Auditory P300 in individuals clinically at risk for psychosis. Int J Psychophysiol 2008;70:192-205.
24. de Wilde OM, Bour LJ, Dingemans PM, Koelman JH, Boeree T, Linszen DH. P300 deficits are present in young first-episode patients with schizophrenia and not in their healthy young siblings. Clin Neurophysiol 2008;119:2721-6.
25. Price GW, Michie PT, Johnston J, Innes-Brown H, Kent A, Clissa P, et al. A multivariate electrophysiological endophenotype, from a unitary cohort, shows greater research utility than any single feature in the Western Australian family study of schizophrenia. Biol Psychiatry 2006;60:1-10.
26. Bramon E, McDonald C, Croft RJ, Landau S, Filbey F, Gruzelier JH, et al. Is the P300 wave an endophenotype for schizophrenia? A meta-analysis and a family study. Neuroimage 2005;27:960-8.
27. Bramon E, Rabe-Hesketh S, Sham P, Murray RM, Frangou S. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res 2004;70:315-29.
28. Cadenhead KS, Light GA, Geyer MA, Braff DL. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry 2000;157:55-9.
29. Hill SK, Harris MS, Herbener ES, Pavuluri M, Sweeney JA. Neurocognitive allied phenotypes for schizophrenia and bipolar disorder. Schizophr Bull 2008;34:743-59.
30. Tecce JJ. Contingent negative variation (CNV) and psychological processes in man. Psychol Bull 1972;77:73-108.
31. Lolas F, de Andraca I. Neuroticism, extraversion and slow brain potentials. Neuropsychobiology 1977;3:12-22.
32. Wilkinson RT, Seales DM. EEG event-related potentials and signal detection. Biol Psychol 1978;7:13-28.
33. Ruchkin DS, Canoune HL, Johnson R, Jr., Ritter W. Working memory and preparation elicit different patterns of slow wave event-related brain potentials. Psychophysiology 1995;32:399-410.
34. Wynn JK, Horan WP, Kring AM, Simons RF, Green MF. Impaired anticipatory event-related potentials in schizophrenia. Int J Psychophysiol 2010;77:141-9.
35. Karayanidis F, Nicholson R, Schall U, Meem L, Fulham R, Michie PT. Switching between univalent task-sets in schizophrenia: ERP evidence of an anticipatory task-set reconfiguration deficit. Clin Neurophysiol 2006;117:2172-90.
36. Li Z, Zheng B, Deng W, Liu X, Zheng Z, Li T. Multi-components of evoked-brain potentials in deficit and nondeficit schizophrenia. Asia Pac Psychiatry 2013;5:69-79.
37. Banerjee N, Sinha VK, Jayaswal M, Desarkar P. The contingent negative variation in remitted paediatric bipolar patients: No evidence of abnormality. Psychiatry Investigation 2013;10:196.
38. Ghadirian AM, Dubrovsky B. A longitudinal CNV study of the evolution and treatment of bipolar illness. Int J Neurosci 1993;72:245-50.
39. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT, Jr. The Schedule for the Deficit syndrome: An instrument for research in schizophrenia. Psychiatry Res 1989;30:119-23.
40. Annett M. A classification of hand preference by association analysis. Br J Psychol 1970;61:303-21.
41. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76.
42. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-35.
43. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
44. Klein C, Heinks T, Andresen B, Berg P, Moritz S. Impaired modulation of the saccadic contingent negative variation preceding antisaccades in schizophrenia. Biol Psychiatry 2000;47:978-90.
45. Linssen AM, Vuurman EF, Sambeth A, Nave S, Spooren W, Vargas G, et al. Contingent negative variation as a dopaminergic biomarker: Evidence from dose-related effects of methylphenidate. Psychopharmacology (Berl) 2011;218:533-42.
46. Verleger R, Wascher E, Wauschkuhn B, Jaskowski P, Allouni B, Trillenberg P, et al. Consequences of altered cerebellar input for the cortical regulation of motor coordination, as reflected in EEG potentials. Exp Brain Res 1999;127:409-22.
47. Bachneff SA, Engelsmann F. Correlates of cerebral event-related slow potentials and psychopathology. Psychol Med 1983;13:763-70.
48. Ivleva EI, Morris DW, Moates AF, Suppes T, Thaker GK, Tamminga CA. Genetics and intermediate phenotypes of the schizophrenia-bipolar disorder boundary. Neurosci Biobehav Rev 2010;34:897-921.
49. Pogarell O, Mulert C, Hegerl U. Event-related potentials in psychiatry. Clin EEG Neurosci 2007;38:25-34.
50. Nagai Y, Critchley HD, Featherstone E, Fenwick PB, Trimble MR, Dolan RJ. Brain activity relating to the contingent negative variation: An fMRI investigation. Neuroimage 2004;21:1232-41.
51. Ioannides AA, Fenwick PB, Lumsden J, Liu MJ, Bamidis PD, Squires KC, et al. Activation sequence of discrete brain areas during cognitive processes: Results from magnetic field tomography. Electroencephalogr Clin Neurophysiol 1994;91:399-402.
52. Lee KM, Chang KH, Roh JK. Subregions within the supplementary motor area activated at different stages of movement preparation and execution. Neuroimage 1999;9:117-23.
53. Liu MJ, Fenwick PB, Lumsden J, Lever C, Stephan KM, Ioannides AA. Averaged and single-trial analysis of cortical activation sequences in movement preparation, initiation, and inhibition. Hum Brain Mapp 1996;4:254-64.
54. Bender S, Weisbrod M, Bornfleth H, Resch F, Oelkers-Ax R. How do children prepare to react? Imaging maturation of motor preparation and stimulus anticipation by late contingent negative variation. Neuroimage 2005;27:737-52.
55. Gomez CM, Marco J, Grau C. Preparatory visuo-motor cortical network of the contingent negative variation estimated by current density. Neuroimage 2003;20:216-24.
56. Galderisi S, Maj M. Deficit schizophrenia: An overview of clinical, biological and treatment aspects. Eur Psychiatry 2009;24:493-500.
57. Galderisi S, Maj M, Mucci A, Cassano GB, Invernizzi G, Rossi A, et al. Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: A multicenter study. Am J Psychiatry 2002;159:983-90.
58. Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 1993;150:1856-61.